4.6 Article

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism

Journal

CELL BIOLOGY AND TOXICOLOGY
Volume 37, Issue 6, Pages 873-890

Publisher

SPRINGER
DOI: 10.1007/s10565-021-09581-5

Keywords

ERG; Endothelial cells; Fibroblasts; Paracrine; Endothelin-1

Funding

  1. National Natural Science Foundation of China [81470516, 81700254]
  2. Key Project of the National Natural Science Foundation [81530012]
  3. National Key R&D Program of China [2018YFC1311300]
  4. Fundamental Research Funds for the Central Universities [2042017kf0085, 2042018kf1032]
  5. Development Center forMedical Science and Technology National Health and Family Planning Commission of the People's Republic of China (The prevention and control project of cardiovascular disease) [2016ZX-008-01]
  6. Science and Technology Planning Projects of Wuhan [2018061005132295]

Ask authors/readers for more resources

The study revealed that the ERG gene in cardiac endothelial cells plays a role in cardiac fibrosis, with ERG deficiency promoting fibrosis and dysfunction. This effect is mediated by increased secretion of endothelin-1 (ET-1) in a paracrine manner, leading to accelerated proliferation, phenotypic transition, and collagen synthesis of cardiac fibroblasts.
Cardiac endothelium communicates closely with adjacent cardiac cells by multiple cytokines and plays critical roles in regulating fibroblasts proliferation, activation, and collagen synthesis during cardiac fibrosis. E26 transformation-specific (ETS)-related gene (ERG) belongs to the ETS transcriptional factor family and is required for endothelial cells (ECs) homeostasis and cardiac development. This study aims at investigating the potential role and molecular basis of ERG in fibrotic remodeling within the adult heart. We observed that ERG was abundant in murine hearts, especially in cardiac ECs, but decreased during cardiac fibrosis. ERG knockdown within murine hearts caused spontaneously cardiac fibrosis and dysfunction, accompanied by the activation of multiple Smad-dependent and independent pathways. However, the direct silence of ERG in cardiac fibroblasts did not affect the expression of fibrotic markers. Intriguingly, ERG knockdown in human umbilical vein endothelial cells (HUVECs) promoted the secretion of endothelin-1 (ET-1), which subsequently accelerated the proliferation, phenotypic transition, and collagen synthesis of cardiac fibroblasts in a paracrine manner. Suppressing ET-1 with either a neutralizing antibody or a receptor blocker abolished ERG knockdown-mediated deleterious effect in vivo and in vitro. This pro-fibrotic effect was also negated by RGD (Arg-Gly-Asp)-peptide magnetic nanoparticles target delivery of ET-1 small interfering RNA to ECs in mice. More importantly, we proved that endothelial ERG overexpression notably prevented pressure overload-induced cardiac fibrosis. Collectively, endothelial ERG alleviates cardiac fibrosis via blocking ET-1-dependent paracrine mechanism and it functions as a candidate for treating cardiac fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available